According to FutureWise analysis the market for gonorrhea therapeutics in 2023 was US$ 1.7 billion, and is expected to reach US$ 2.5 billion by 2031 at a CAGR of 5.3%.
The bacteria Neisseria gonorrhoeae is the source of the sexually transmitted disease gonorrhea. It frequently affects the urethra, eyes, throat, vagina, anus, and female reproductive tract since these are warm, wet bodily parts. Unprotected intercourse is how gonorrhea is spread from one person to another. If the mother is infected, the baby may become infected during delivery. Typically, symptoms appear two to fourteen days following exposure. Unfortunately, some gonorrhea sufferers never show any overt symptoms. When a person has no noticeable symptoms, they are more prone to infect other partners.
Because N. gonorrhoeae is capable of quickly gaining resistance to numerous antibiotic classes, gonococcal infections are currently a serious issue worldwide. The antibiotics sulfonamides, penicillin, tetracyclines, and fluoroquinolones have become less effective against N. gonorrhoeae over time. Cephalosporins are currently the first-line treatment, however there have lately been incidences of resistance to those drugs documented. In women, gonorrhea frequently has no symptoms, whereas in men, it frequently does. Females who experience symptoms typically present with vaginal discharge, dysuria, dyspareunia, abnormal uterine bleeding, lower abdomen pain, and/or rectal pain. Male symptoms include testicular or rectal pain, dysuria, and urethral discharge and/or itching. The most frequently affected anatomical sites are the urethra and cervix, followed by the anal and pharyngeal regions. On the initial clinical visit, empiric therapy for gonococcal infections is frequently given based on history considerations such sexual activity with a person who has a STI or a clinical exam suspected of a STI, such as penile drip or abnormal vaginal discharge.
The bacteria Neisseria gonorrhoeae is the prevalent sexually transmitted illness known as gonorrhea. Both men and women can be affected by the condition, which if untreated can cause major health issues like infertility and an elevated risk of HIV transmission. Due to growing gonorrhea prevalence and increased public awareness of the condition, the worldwide market for gonorrhea therapeutics has seen rapid expansion in recent years. A number of reasons, including the availability of efficient medications, rising healthcare costs, and growing disease awareness, are driving the gonorrhea therapeutics market.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Gonorrhea-Therapeutics-Market/9153
Gonorrhea Therapeutics Market Segmentation:
By Gonococcal Infection
- Uncomplicated Gonococcal Infection
- Gonococcal Arthritis
- Gonococcal Meningitis and Endocarditis
By Treatment
- Monotherapy
- Dual Therapy
By Route of Administration
- Oral
- Injectable
By Gender
- Women
- Men
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Gonorrhea Therapeutics Market:
- Hologic, Inc.
- Merck & Co.
- Pfizer Inc.
- AstraZeneca
- Danaher
- Abbott
- Becton Dickinson and Company
- F. Hoffmann-La Roche Ltd.
- Lupin Pharmaceuticals
- Teligent, Inc.
- Bayer AG
- GlaxoSmithKline Plc.
- Novartis AG.
- Allergan plc
- Sanofi S.A.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Baxter International Inc.
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=9153%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Gonorrhea Therapeutics Market By Gonococcal Infection, By Treatment, By Route of Administration, By Gender, By Distribution Channel and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: [email protected]
FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
